Quantification of T-cell dynamics during latent cytomegalovirus infection in humans. 2021

Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Cytomegalovirus (CMV) infection has a major impact on the T-cell pool, which is thought to be associated with ageing of the immune system. The effect on the T-cell pool has been interpreted as an effect of CMV on non-CMV specific T-cells. However, it remains unclear whether the effect of CMV could simply be explained by the presence of large, immunodominant, CMV-specific memory CD8+ T-cell populations. These have been suggested to establish through gradual accumulation of long-lived cells. However, little is known about their maintenance. We investigated the effect of CMV infection on T-cell dynamics in healthy older adults, and aimed to unravel the mechanisms of maintenance of large numbers of CMV-specific CD8+ T-cells. We studied the expression of senescence, proliferation, and apoptosis markers and quantified the in vivo dynamics of CMV-specific and other memory T-cell populations using in vivo deuterium labelling. Increased expression of late-stage differentiation markers by CD8+ T-cells of CMV+ versus CMV- individuals was not solely explained by the presence of large, immunodominant CMV-specific CD8+ T-cell populations. The lifespans of circulating CMV-specific CD8+ T-cells did not differ significantly from those of bulk memory CD8+ T-cells, and the lifespans of bulk memory CD8+ T-cells did not differ significantly between CMV- and CMV+ individuals. Memory CD4+ T-cells of CMV+ individuals showed increased expression of late-stage differentiation markers and decreased Ki-67 expression. Overall, the expression of senescence markers on T-cell populations correlated positively with their expected in vivo lifespan. Together, this work suggests that i) large, immunodominant CMV-specific CD8+ T-cell populations do not explain the phenotypical differences between CMV+ and CMV- individuals, ii) CMV infection hardly affects the dynamics of the T-cell pool, and iii) large numbers of CMV-specific CD8+ T-cells are not due to longer lifespans of these cells.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085343 Latent Infection Delayed infection of the host by a dormant or inactive pathogen. Infection Reactivation,Reactivated Infection,Reactivation Infection,Infection Reactivations,Infection, Latent,Infection, Reactivated,Infection, Reactivation,Latent Infections,Reactivation Infections,Reactivation, Infection
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
July 2008, Journal of immunology (Baltimore, Md. : 1950),
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
May 2001, Transplantation proceedings,
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
June 2008, Medical microbiology and immunology,
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
January 1983, Archives of virology,
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
January 2004, AIDS (London, England),
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
July 2014, Brain, behavior, and immunity,
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
March 2018, Pathogens (Basel, Switzerland),
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
January 2014, Molecular systems biology,
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
January 2016, Bing du xue bao = Chinese journal of virology,
Sara P H van den Berg, and Lyanne Y Derksen, and Julia Drylewicz, and Nening M Nanlohy, and Lisa Beckers, and Josien Lanfermeijer, and Stephanie N Gessel, and Martijn Vos, and Sigrid A Otto, and Rob J de Boer, and Kiki Tesselaar, and José A M Borghans, and Debbie van Baarle
September 2010, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!